afdx 384 has been researched along with guanosine monophosphate in 1 studies
| Studies (afdx 384) | Trials (afdx 384) | Recent Studies (post-2010) (afdx 384) | Studies (guanosine monophosphate) | Trials (guanosine monophosphate) | Recent Studies (post-2010) (guanosine monophosphate) |
|---|---|---|---|---|---|
| 78 | 0 | 6 | 1,526 | 20 | 325 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araujo, DM; Hefti, F; Lapchak, PA | 1 |
1 other study(ies) available for afdx 384 and guanosine monophosphate
| Article | Year |
|---|---|
Regulation of hippocampal muscarinic receptor function by chronic nerve growth factor treatment in adult rats with fimbrial transections.
Topics: Animals; Autoradiography; Female; Guanosine Monophosphate; Hippocampus; In Vitro Techniques; Injections, Intraventricular; Inosine Triphosphate; Nerve Growth Factors; Oxotremorine; Parasympathetic Nervous System; Parasympatholytics; Pirenzepine; Quinuclidinyl Benzilate; Rats; Rats, Wistar; Receptors, Muscarinic; Second Messenger Systems | 1993 |